Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...

A review of recent studies of angiotensin II receptor blockers in hypertension, acute myocardial infarction, heart failure, and nephropathy provide some data on specific drugs, doses, and risk ...

A recent study suggests that a commonly prescribed type of blood pressure medication, known as angiotensin receptor blockers ...

a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide ...

Newer drugs act on the renin–angiotensin ... In terms of branded sales, the angiotensin II receptor blocker class dominates with five of the top ten antihypertensives belonging to this class ...

A recent study from Columbia University has raised important questions about the medications used to treat high blood ...

Dimerix has achieved a key milestone in its ACTION3 phase III trial of lead asset DMX-200 into focal segmental ...

Abstract The purpose of this study was to assess the inhibitory effect of TCV-116, an orally active angiotensin II (Ang ... and long-lasting antagonist of Ang II in men. TCV-116, a new AT 1 receptor ...

Abstract We investigated the effects of angiotensin ... feedback Ang II receptor in hypertensive patients produces modest increases of plasma renin activity and Ang II that do not appear to affect the ...

There are currently no drugs currently approved specifically ... with FSGS who are receiving a stable dose of an angiotensin II receptor blocker (ARB). Once the ARB dose is stable, patients ...

Acute coronary syndrome (ACS) is a term used to describe a range of conditions resulting from the sudden reduction or ...